Literature DB >> 22492685

An evolutionary view of the mechanism for immune and genome diversity.

Lucia Kato1, Andre Stanlie, Nasim A Begum, Maki Kobayashi, Masatoshi Aida, Tasuku Honjo.   

Abstract

An ortholog of activation-induced cytidine deaminase (AID) was, evolutionarily, the first enzyme to generate acquired immune diversity by catalyzing gene conversion and probably somatic hypermutation (SHM). AID began to mediate class switch recombination (CSR) only after the evolution of frogs. Recent studies revealed that the mechanisms for generating immune and genetic diversity share several critical features. Meiotic recombination, V(D)J recombination, CSR, and SHM all require H3K4 trimethyl histone modification to specify the target DNA. Genetic instability related to dinucleotide or triplet repeats depends on DNA cleavage by topoisomerase 1, which also initiates DNA cleavage in both SHM and CSR. These similarities suggest that AID hijacked the basic mechanism for genome instability when AID evolved in jawless fish. Thus, the risk of introducing genome instability into nonimmunoglobulin loci is unavoidable but tolerable compared with the advantage conferred on the host of being protected against pathogens by the enormous Ig diversification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492685     DOI: 10.4049/jimmunol.1102397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Mechanisms of epigenetic deregulation in lymphoid neoplasms.

Authors:  Yanwen Jiang; Katerina Hatzi; Rita Shaknovich
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

Review 2.  Control of Transposon-Mediated Directed Mutation by the Escherichia coli Phosphoenolpyruvate:Sugar Phosphotransferase System.

Authors:  Milton H Saier; Zhongge Zhang
Journal:  J Mol Microbiol Biotechnol       Date:  2015-07-09

Review 3.  αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy.

Authors:  Ellis L Reinherz
Journal:  Cancer Immunol Res       Date:  2015-04       Impact factor: 11.151

4.  A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.

Authors:  Carin I M Dahlberg; Minghui He; Torkild Visnes; Magda Liz Torres; Elena M Cortizas; Ramiro E Verdun; Lisa S Westerberg; Eva Severinson; Lena Ström
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

5.  Functional requirements of AID's higher order structures and their interaction with RNA-binding proteins.

Authors:  Samiran Mondal; Nasim A Begum; Wenjun Hu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

6.  Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase.

Authors:  Wenjun Hu; Nasim A Begum; Samiran Mondal; Andre Stanlie; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

7.  APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination.

Authors:  Jianliang Xu; Afzal Husain; Wenjun Hu; Tasuku Honjo; Maki Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 8.  Diversity of Immunoglobulin (Ig) Isotypes and the Role of Activation-Induced Cytidine Deaminase (AID) in Fish.

Authors:  Bhakti Patel; Rajanya Banerjee; Mrinal Samanta; Surajit Das
Journal:  Mol Biotechnol       Date:  2018-06       Impact factor: 2.695

9.  Single nucleotide editing without DNA cleavage using CRISPR/Cas9-deaminase in the sea urchin embryo.

Authors:  Saba Shevidi; Alicia Uchida; Natalie Schudrowitz; Gary M Wessel; Mamiko Yajima
Journal:  Dev Dyn       Date:  2017-10-13       Impact factor: 3.780

Review 10.  The origin of recurrent translocations in recombining lymphocytes: a balance between break frequency and nuclear proximity.

Authors:  Pedro P Rocha; Jane A Skok
Journal:  Curr Opin Cell Biol       Date:  2013-03-13       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.